Friedrich W. Mohr - Concepedia

Author

Friedrich W. Mohr

Also Known As

A S Coulson, Dietrich Andresen, F Mohr, F. Mohr, F. W. Mohr, FRIEDRICH W. MOHR, Fiedrich W. Mohr, Friedrich Mohr, Friedrich W Mohr, Friedrich W Mohr, MD

699

Publications

37.9K

Citations

H-Index

201

Concepts

All Affiliations

Leipzig Heart Institute Leipzig University Deutsches Herzzentrum der Charité Erasmus MC Erasmus University Rotterdam

About

Friedrich W. Mohr is an author at Leipzig Heart Institute specializing in medicine, surgery, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	64	187	16.3K
2	Engineering	11	11	395
3	Health Sciences	7	7	477
4	Natural Sciences	1	1	34
5	Nursing	1	1	54

Friedrich W. Mohr

347

Publications

35.1K

Citations

H-Index

Page 1

	Year	Citations
Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease Patrick W. Serruys, Marie‐Claude Morice, A. Pieter Kappetein, New England Journal of Medicine	2009	4.3K
Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial Friedrich W. Mohr, Marie-Claude Morice, A. Pieter Kappetein, The Lancet Cardiac SurgeryPercutaneous Coronary InterventionEndovascular TechniqueCardiovascular DiseaseClinical Syntax Trial	2013	1.8K
Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II Vasim Farooq, David van Klaveren, Ewout W. Steyerberg, The Lancet Cardiac SurgeryPercutaneous Coronary InterventionCardiovascular DiseaseClinical Decision-makingMedicine	2013	813
Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial Marie-Claude Morice, Patrick W. Serruys, A. Pieter Kappetein, Circulation	2010	640
Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients Jan Bucerius, Jan Gummert, Michael A. Borger, The Annals of Thoracic Surgery Adult Cardiac SurgeryCerebrovascular DiseaseThrombosisStrokeVascular Surgery	2003	619
Transapical Minimally Invasive Aortic Valve Implantation Thomas Walther, Paul Simon, Todd Dewey, Circulation	2007	619
Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock Ardawan Rastan, A Dege, Matthias Mohr, Journal of Thoracic and Cardiovascular Surgery Cardiogenic ShockCardiopulmonary ResuscitationCardiovascular DiseaseLate OutcomesConsecutive Adult Patients	2010	597
Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial A. Pieter Kappetein, Ted Feldman, Michael J. Mack, European Heart Journal	2011	562
Five-Year Outcomes in Patients With Left Main Disease Treated With Either Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Trial Marie-Claude Morice, Patrick W. Serruys, A. Pieter Kappetein, Circulation	2014	526
Quantification of Incomplete Revascularization and its Association With Five-Year Mortality in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) Trial Validation of the Residual SYNTAX Score Vasim Farooq, Patrick W. Serruys, Christos V. Bourantas, Circulation	2013	393

Page 1